Chiung‐Kuei Huang

Tulane University — United States

Medicine · Health Sciences

24h-index1.4kcitations92works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(22), RNA modifications and cancer(19), Liver Disease Diagnosis and Treatment(18), Ubiquitin and proteasome pathways(15), Epigenetics and DNA Methylation(8)

Publications91 total

Gender Differences in Healthy Eating Index as Informed by the Awareness of Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease
Livers·2025Open Access
Liver TET1 promotesmetabolic dysfunction-associated steatotic liver disease by upregulating CD36
Physiology·2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
EMBO Molecular Medicine·2025· 2 citedOpen Access
The Complexity of SIRT2 in Chronic Liver Disease: Liver SIRT2 Promotes Hepatocellular Carcinoma Development
Cellular and Molecular Gastroenterology and Hepatology·2025· 1 citedOpen Access
Convergence of Alcohol Consumption and Dietary Quality in US Adults Who Currently Drink Alcohol: An Analysis of Two Core Risk Factors of Liver Disease
Nutrients·2024· 5 citedOpen Access
Abstract A077: The role of RhoV in basal-like pancreatic cancer
Cancer Research·2024
RISKY BEHAVIORS WITH NONALCOHOLIC FATTY LIVER (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) AMONG OLDER ADULTS
Innovation in Aging·2023Open Access
Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase
Cancer Letters·2023· 5 citedOpen Access
Exclusive liquor and cocktail consumption is associated with at‐risk fibrosis among nonheavy alcohol users with metabolic dysfunction‐associated steatotic liver disease
Alcohol Clinical and Experimental Research·2023· 4 citedOpen Access
Sugar-Sweetened Beverages and Artificially Sweetened Beverages Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Nutrients·2023· 25 citedOpen Access
Sugar-Sweetened Beverages and Artificially Sweetened Beverage Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Preprints.org·2023· 8 citedOpen Access
Molecular profiling reveals potential targets in cholangiocarcinoma
World Journal of Gastroenterology·2023· 4 citedOpen Access
miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury
Hepatology Communications·2023· 22 citedOpen Access
Supplementary Figure 3 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
Supplementary Figure 6 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
Supplementary Figure 5 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
Supplementary Figure 4 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
Supplementary Figure 1 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
Supplementary Table 1 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
Supplementary Table 4 from Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Chawnshang Chang(17), Soo Ok Lee(13), Shaolei Lu(12), Jack R. Wands(9), Jie Luo(9), Katsuya Nagaoka(9), Kevin Cao(9), Chengcheng Ji(7), Xuewei Bai(7), Joud Mulla(6), Kuo‐Pao Lai(5), Shuyuan Yeh(5), Yoshifumi Iwagami(5), Rolf I. Carlson(5), William F. Mueller(5), Tung‐Sung Tseng(5), Peng–Sheng Ting(5), Hui‐Yi Lin(5), Hong‐Yo Kang(4), Jing Zou(4)